Hanmi Pharm Reports Q2 Operating Profit of 29.6 Billion KRW, Up 86.4% YoY
[Asia Economy Reporter Myunghwan Lee] Hanmi Pharm announced on the 18th that its operating profit for the second quarter of this year was tentatively estimated at 29.569 billion KRW, an 86.4% increase compared to the same period last year.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
During the same period, sales increased by 13.3% to 316.52 billion KRW, and net profit increased by 179.1% to 23.07 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
